Publications by authors named "Verla Laager"
Article Synopsis
- Diagnostic variables from insertable cardiac monitors can help identify heart failure (HF) patients at risk, but high-risk alerts must be paired with interventions to improve patient outcomes.
- The ALLEVIATE-HF study involved patients with recent HF events, using a risk score based on various monitor diagnostics to guide intervention protocols, including diuretic uptitration.
- Results showed that the intervention was generally safe, with positive symptom resolution in most cases, indicating the feasibility of tailored medication management based on high-risk alerts.
Background: Device repositioning during Micra leadless pacemaker implantation may be required to achieve optimal pacing thresholds.
Objective: The purpose of this study was to describe the natural history of acute elevated Micra vs traditional transvenous lead thresholds.
Methods: Micra study VVI patients with threshold data (at 0.
Background: A leadless intracardiac transcatheter pacing system has been designed to avoid the need for a pacemaker pocket and transvenous lead.
Methods: In a prospective multicenter study without controls, a transcatheter pacemaker was implanted in patients who had guideline-based indications for ventricular pacing. The analysis of the primary end points began when 300 patients reached 6 months of follow-up.
Aims: Permanent cardiac pacing is the only effective treatment for symptomatic bradycardia, but complications associated with conventional transvenous pacing systems are commonly related to the pacing lead and pocket. We describe the early performance of a novel self-contained miniaturized pacemaker.
Methods And Results: Patients having Class I or II indication for VVI pacing underwent implantation of a Micra transcatheter pacing system, from the femoral vein and fixated in the right ventricle using four protractible nitinol tines.
Aims: Recent advances in miniaturization technologies and battery chemistries have made it possible to develop a pacemaker small enough to implant within the heart while still aiming to provide similar battery longevity to conventional pacemakers. The Micra Transcatheter Pacing System is a miniaturized single-chamber pacemaker system that is delivered via catheter through the femoral vein. The pacemaker is implanted directly inside the right ventricle of the heart, eliminating the need for a device pocket and insertion of a pacing lead, thereby potentially avoiding some of the complications associated with traditional pacing systems.
View Article and Find Full Text PDF